https://www.delta-dossier.de/de/delta-dossier-readiness-check 2026-08-03 monthly 0.9 https://www.delta-dossier.de/en/delta-dossier-readiness-check 2026-08-03 monthly 0.86 https://www.delta-dossier.de/ 2026-06-17 weekly 1 https://www.delta-dossier.de/en 2026-06-17 weekly 0.9 https://www.delta-dossier.de/de/insights 2026-06-17 monthly 0.86 https://www.delta-dossier.de/en/insights 2026-06-17 monthly 0.82 https://www.delta-dossier.de/de/jca-insights 2026-07-28 monthly 0.85 https://www.delta-dossier.de/en/jca-insights 2026-07-28 monthly 0.81 https://www.delta-dossier.de/de/insights/eu-hta-deutschland 2026-08-31 monthly 0.85 https://www.delta-dossier.de/en/insights/eu-hta-germany 2026-08-31 monthly 0.75 https://www.delta-dossier.de/de/insights/delta-dossier-amnog-jca 2026-08-17 monthly 0.82 https://www.delta-dossier.de/en/insights/delta-dossier-amnog-jca 2026-08-17 monthly 0.72 https://www.delta-dossier.de/de/insights/tovorafenib-jca-gba-nutzenbewertung 2026-08-17 monthly 0.78 https://www.delta-dossier.de/en/insights/tovorafenib-jca-gba-benefit-assessment 2026-08-17 monthly 0.75 https://www.delta-dossier.de/de/insights/tovorafenib-ojemda-jca-delta-dossier 2026-06-17 monthly 0.76 https://www.delta-dossier.de/en/insights/tovorafenib-ojemda-jca-delta-dossier 2026-06-17 monthly 0.72 https://www.delta-dossier.de/de/insights/joint-clinical-assessment-evidenzbewertung 2026-07-09 monthly 0.75 https://www.delta-dossier.de/en/insights/joint-clinical-assessment-evidence-assessment 2026-07-09 monthly 0.71 https://www.delta-dossier.de/de/insights/gkv-beitragssatzstabilisierungsgesetz-eu-hta-amnog 2026-07-29 monthly 0.76 https://www.delta-dossier.de/en/insights/statutory-health-insurance-contribution-stabilization-act-eu-hta-amnog 2026-07-29 monthly 0.72 https://www.delta-dossier.de/de/insights/jca-abgebrochen-deutschland-amnog 2026-06-26 monthly 0.74 https://www.delta-dossier.de/en/insights/jca-discontinued-germany-amnog 2026-06-26 monthly 0.7 https://www.delta-dossier.de/de/insights/individualised-treatment-comparator-jca 2026-06-17 monthly 0.72 https://www.delta-dossier.de/en/insights/individualised-treatment-comparator-jca 2026-06-17 monthly 0.68 https://www.delta-dossier.de/de/insights/publications 2026-06-17 monthly 0.72 https://www.delta-dossier.de/en/insights/publications 2026-06-17 monthly 0.68 https://www.delta-dossier.de/de/insights/publications/methods-gaps-eu-jca-local-hta 2025-01-01 yearly 0.68 https://www.delta-dossier.de/en/insights/publications/methods-gaps-eu-jca-local-hta 2025-01-01 yearly 0.64 https://www.delta-dossier.de/de/insights/publications/rwe-eu-htar-jca 2026-01-01 yearly 0.68 https://www.delta-dossier.de/en/insights/publications/rwe-eu-htar-jca 2026-01-01 yearly 0.64 https://www.delta-dossier.de/de/amnog-nutzenbewertung 2026-08-31 monthly 0.84 https://www.delta-dossier.de/en/amnog-process-germany 2026-07-28 monthly 0.82 https://www.delta-dossier.de/en/amnog-legislation-germany 2026-07-28 monthly 0.78 https://www.delta-dossier.de/en/amnog-dossier 2026-08-31 monthly 0.82 https://www.delta-dossier.de/en/jca-dossier-amnog-germany 2026-07-28 monthly 0.85 https://www.delta-dossier.de/de/amnog 2026-07-28 monthly 0.86 https://www.delta-dossier.de/en/amnog-germany 2026-07-28 monthly 0.88